BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

524 related articles for article (PubMed ID: 32408216)

  • 21. Perfluoroalkyl substances and lipid concentrations in plasma during pregnancy among women in the Norwegian Mother and Child Cohort Study.
    Starling AP; Engel SM; Whitworth KW; Richardson DB; Stuebe AM; Daniels JL; Haug LS; Eggesbø M; Becher G; Sabaredzovic A; Thomsen C; Wilson RE; Travlos GS; Hoppin JA; Baird DD; Longnecker MP
    Environ Int; 2014 Jan; 62():104-12. PubMed ID: 24189199
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Transfer of perfluoroalkyl substances from mother to fetus in a Spanish birth cohort.
    Manzano-Salgado CB; Casas M; Lopez-Espinosa MJ; Ballester F; Basterrechea M; Grimalt JO; Jiménez AM; Kraus T; Schettgen T; Sunyer J; Vrijheid M
    Environ Res; 2015 Oct; 142():471-8. PubMed ID: 26257032
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Maternal serum concentrations of perfluoroalkyl substances during pregnancy and gestational weight gain: The Avon Longitudinal Study of Parents and Children.
    Marks KJ; Jeddy Z; Flanders WD; Northstone K; Fraser A; Calafat AM; Kato K; Hartman TJ
    Reprod Toxicol; 2019 Dec; 90():8-14. PubMed ID: 31415809
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Per- and polyfluoroalkyl substances and blood pressure in pre-diabetic adults-cross-sectional and longitudinal analyses of the diabetes prevention program outcomes study.
    Lin PD; Cardenas A; Hauser R; Gold DR; Kleinman KP; Hivert MF; Calafat AM; Webster TF; Horton ES; Oken E
    Environ Int; 2020 Apr; 137():105573. PubMed ID: 32088543
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Concentrations of perfluoroalkyl and polyfluoroalkyl substances and blood glucose in pregnant women.
    Ren Y; Jin L; Yang F; Liang H; Zhang Z; Du J; Song X; Miao M; Yuan W
    Environ Health; 2020 Aug; 19(1):88. PubMed ID: 32807188
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prenatal perfluoroalkyl substances exposure and maternal sex steroid hormones across pregnancy.
    Rivera-Núñez Z; Kinkade CW; Khoury L; Brunner J; Murphy H; Wang C; Kannan K; Miller RK; O'Connor TG; Barrett ES
    Environ Res; 2023 Mar; 220():115233. PubMed ID: 36621543
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Concentrations of perfluoroalkyl substances (PFASs) in human embryonic and fetal organs from first, second, and third trimester pregnancies.
    Mamsen LS; Björvang RD; Mucs D; Vinnars MT; Papadogiannakis N; Lindh CH; Andersen CY; Damdimopoulou P
    Environ Int; 2019 Mar; 124():482-492. PubMed ID: 30684806
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Systematic review and meta-analysis of epidemiologic data on vaccine response in relation to exposure to five principal perfluoroalkyl substances.
    Crawford L; Halperin SA; Dzierlenga MW; Skidmore B; Linakis MW; Nakagawa S; Longnecker MP
    Environ Int; 2023 Feb; 172():107734. PubMed ID: 36764183
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Exposure to endocrine-disrupting chemicals and risk of gestational hypertension and preeclampsia: A systematic review and meta-analysis.
    Hirke A; Varghese B; Varade S; Adela R
    Environ Pollut; 2023 Jan; 317():120828. PubMed ID: 36481468
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Exposure to per- and polyfluoroalkyl substances in early pregnancy and risk of cerebral palsy in children.
    Vilhelmsson A; Rylander L; Jöud A; Lindh CH; Mattsson K; Liew Z; Guo P; Ritz B; Källén K; Thacher JD
    Sci Total Environ; 2023 Nov; 899():165622. PubMed ID: 37474063
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prenatal exposure to 11 perfluoroalkyl substances and fetal growth: A large-scale, prospective birth cohort study.
    Kashino I; Sasaki S; Okada E; Matsuura H; Goudarzi H; Miyashita C; Okada E; Ito YM; Araki A; Kishi R
    Environ Int; 2020 Mar; 136():105355. PubMed ID: 32029284
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Associations between per- and polyfluoroalkyl substances (PFAS) and diabetes in two population-based cohort studies from Sweden.
    Dunder L; Salihovic S; Elmståhl S; Lind PM; Lind L
    J Expo Sci Environ Epidemiol; 2023 Sep; 33(5):748-756. PubMed ID: 36964247
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Exposure to organophosphorus and organochlorine pesticides, perfluoroalkyl substances, and polychlorinated biphenyls in pregnancy and the association with impaired glucose tolerance and gestational diabetes mellitus: The MIREC Study.
    Shapiro GD; Dodds L; Arbuckle TE; Ashley-Martin J; Ettinger AS; Fisher M; Taback S; Bouchard MF; Monnier P; Dallaire R; Morisset AS; Fraser W
    Environ Res; 2016 May; 147():71-81. PubMed ID: 26852007
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Maternal Plasma Perfluoroalkyl Substances and Miscarriage: A Nested Case-Control Study in the Danish National Birth Cohort.
    Liew Z; Luo J; Nohr EA; Bech BH; Bossi R; Arah OA; Olsen J
    Environ Health Perspect; 2020 Apr; 128(4):47007. PubMed ID: 32319790
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Do perfluoroalkyl substances affect metabolic function and plasma lipids?--Analysis of the 2007-2009, Canadian Health Measures Survey (CHMS) Cycle 1.
    Fisher M; Arbuckle TE; Wade M; Haines DA
    Environ Res; 2013 Feb; 121():95-103. PubMed ID: 23266098
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Gestational Perfluoroalkyl Substance Exposure and DNA Methylation at Birth and 12 Years of Age: A Longitudinal Epigenome-Wide Association Study.
    Liu Y; Eliot MN; Papandonatos GD; Kelsey KT; Fore R; Langevin S; Buckley J; Chen A; Lanphear BP; Cecil KM; Yolton K; Hivert MF; Sagiv SK; Baccarelli AA; Oken E; Braun JM
    Environ Health Perspect; 2022 Mar; 130(3):37005. PubMed ID: 35266797
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Environmental exposure to perfluoroalkyl substances in early pregnancy, maternal glucose homeostasis and the risk of gestational diabetes: A prospective cohort study.
    Yu G; Jin M; Huang Y; Aimuzi R; Zheng T; Nian M; Tian Y; Wang W; Luo Z; Shen L; Wang X; Du Q; Xu W; Zhang J;
    Environ Int; 2021 Nov; 156():106621. PubMed ID: 33984575
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Human serum poly- and perfluoroalkyl substance concentrations and their associations with gestational diabetes mellitus.
    Zhang Y; Chen R; Gao Y; Qu J; Wang Z; Zhao M; Bai X; Jin H
    Environ Pollut; 2023 Jan; 317():120833. PubMed ID: 36493933
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Plasma Perfluoroalkyl and Polyfluoroalkyl Substances Concentration and Menstrual Cycle Characteristics in Preconception Women.
    Zhou W; Zhang L; Tong C; Fang F; Zhao S; Tian Y; Tao Y; Zhang J;
    Environ Health Perspect; 2017 Jun; 125(6):067012. PubMed ID: 28657892
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Perfluoroalkyl substances and time to pregnancy in couples from Greenland, Poland and Ukraine.
    Jørgensen KT; Specht IO; Lenters V; Bach CC; Rylander L; Jönsson BA; Lindh CH; Giwercman A; Heederik D; Toft G; Bonde JP
    Environ Health; 2014 Dec; 13():116. PubMed ID: 25533644
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 27.